Cannapharmarx Inc (CPMD): $30m Rev / 136,183,783 OS = .22 pps $30...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Wednesday, 01/19/2022 10:12:53 AM

Wednesday, January 19, 2022 10:12:53 AM

$30m Rev / 136,183,783 OS = .22 pps
$30m Rev x 20 years / (136,183,783 OS) = $4.40 pps

Keep Last Read

Next 10 Prev Next

Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/22/2024 12:55:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 05:02:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:01:08 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:05:45 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 08:01:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 06:51:01 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 06:38:01 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/13/2023 02:20:32 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 06:13:01 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/22/2023 06:51:11 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/01/2023 05:08:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 08:21:42 PM

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

Only $200 per official company press release!